CD8A and neoplasm: Highly accumulated HA serves as an immune‐suppressive barrier in the tumor environment, whereas oligo‐HA molecules stemming from HA degradation act as Toll‐like receptor‐4 agonists leading to the activation of CD103+ dendritic cells and subsequently tumor‐specific CD8+ T cells [172].